Home > Share Market > Stocks > Solara active pharma sciences > Financial Statements > SOLARA Key Financial Ratios

Solara active pharma sciences Financial Statements

Solara active pharma sciences Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 -
Growth matrix (%)        
Revenue growth 22.30 136 -- --
Op profit growth 48.70 335 -- --
EBIT growth 58.70 660 -- --
Net profit growth 93.20 30,301 -- --
Profitability ratios (%)        
OPM 23.90 19.60 10.60 --
EBIT margin 18.90 14.60 4.53 --
Net profit margin 13.70 8.67 0.07 --
RoCE 14.50 11.40 -- --
RoNW 4.14 3.10 -- --
RoA 2.63 1.69 -- --
Per share ratios ()        
EPS 61.60 42.70 0.14 --
Dividend per share 7 2 -- --
Cash EPS 31.40 7.61 (15) --
Book value per share 442 404 310 --
Valuation ratios        
P/E 22.60 10.40 -- --
P/CEPS 44.40 58.20 -- --
P/B 3.15 1.10 -- --
EV/EBIDTA 13.10 6.47 -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (0.10) (0.30) 71.10 --
Liquidity ratios        
Debtor days 80.20 67.50 -- --
Inventory days 64.90 64.50 -- --
Creditor days (80) (94) -- --
Leverage ratios        
Interest coverage (3.60) (2.50) (1) --
Net debt / equity 0.27 0.61 0.77 --
Net debt / op. profit 1.09 2.56 9.83 --
Cost breakup ()        
Material costs (45) (45) (52) --
Employee costs (14) (15) (13) --
Other costs (17) (20) (24) --

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000